SEC Form 4 · accession 0001209191-17-018785
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Carey
Officer — EVP, Chief Business Officer
Period of report
Mar 5, 2017
Accepted (ET)
Mar 7, 2017 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 5, 2017 | M | 31,025 | — | A | 31,625 | D | |
| Ordinary Shares | Mar 5, 2017 | F | 14,268 | $16.11 | D | 17,357 | D | |
| Ordinary Shares | holding | — | — | — | 95,408 | I | By Robert F. Carey III Trust dated 4/24/2001 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 5, 2017 | M | 31,025 | D | — | — | Ordinary Shares | 31,025 | 31,025 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On March 5, 2014, the reporting person was granted 124,100 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.